We treated Hela cells with Fludarabine (for STAT1 inhibition), Nifuroxazide (for STAT1/3/5 inhibition), BAY11-7082 (for NF-κB inhibition), SB203580 (for p38 MAPK inhibition), SP600125 (for JNK1/2/3 inhibition) or U0126 (for MEK1/2 inhibition) and the DMB expression was examined after MT2 infection.